Literature DB >> 33926043

Preclinical Detection of Alpha-Synuclein Seeding Activity in the Colon of a Transgenic Mouse Model of Synucleinopathy by RT-QuIC.

Jung-Youn Han1, Chaewon Shin2, Young Pyo Choi1.   

Abstract

In synucleinopathies such as Parkinson's disease (PD) and dementia with Lewy body (DLB), pathological alpha-synuclein (α-syn) aggregates are found in the gastrointestinal (GI) tract as well as in the brain. In this study, using real-time quaking-induced conversion (RT-QuIC), we investigated the presence of α-syn seeding activity in the brain and colon tissue of G2-3 transgenic mice expressing human A53T α-syn. Here we show that pathological α-syn aggregates with seeding activity were present in the colon of G2-3 mice as early as 3 months old, which is in the presymptomatic stage prior to the observation of any neurological abnormalities. In contrast, α-syn seeding activity was not detectable in 3 month-old mouse brains and only identified at 6 months of age in one of three mice. In the symptomatic stage of 12 months of age, RT-QuIC seeding activity was consistently detectable in both the brain and colon of G2-3 mice. Our results indicate that the RT-QuIC assay can presymptomatically detect pathological α-syn aggregates in the colon of G2-3 mice several months prior to their detection in brain tissue.

Entities:  

Keywords:  Parkinson’s disease; RT-QuIC; alpha-synuclein; synucleinopathy

Year:  2021        PMID: 33926043     DOI: 10.3390/v13050759

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  58 in total

Review 1.  Alpha-synuclein and neurodegenerative diseases.

Authors:  M Goedert
Journal:  Nat Rev Neurosci       Date:  2001-07       Impact factor: 34.870

2.  Incidental Lewy body disease restricted to the heart and stellate ganglia.

Authors:  Yasuo Miki; Fumiaki Mori; Koichi Wakabayashi; Naohito Kuroda; Satoshi Orimo
Journal:  Mov Disord       Date:  2009-11-15       Impact factor: 10.338

3.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

4.  Endogenous Brain Lipids Inhibit Prion Amyloid Formation In Vitro.

Authors:  Clare E Hoover; Kristen A Davenport; Davin M Henderson; Mark D Zabel; Edward A Hoover
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

5.  Propagation of prions causing synucleinopathies in cultured cells.

Authors:  Amanda L Woerman; Jan Stöhr; Atsushi Aoyagi; Ryan Rampersaud; Zuzana Krejciova; Joel C Watts; Takao Ohyama; Smita Patel; Kartika Widjaja; Abby Oehler; David W Sanders; Marc I Diamond; William W Seeley; Lefkos T Middleton; Steve M Gentleman; Daniel A Mordes; Thomas C Südhof; Kurt Giles; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-18       Impact factor: 11.205

6.  Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

Authors:  P H Tu; J E Galvin; M Baba; B Giasson; T Tomita; S Leight; S Nakajo; T Iwatsubo; J Q Trojanowski; V M Lee
Journal:  Ann Neurol       Date:  1998-09       Impact factor: 10.422

7.  Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.

Authors:  Alex Iranzo; Graham Fairfoul; Anutra Chumbala Na Ayudhaya; Monica Serradell; Ellen Gelpi; Isabel Vilaseca; Raquel Sanchez-Valle; Carles Gaig; Joan Santamaria; Eduard Tolosa; Renata L Riha; Alison J E Green
Journal:  Lancet Neurol       Date:  2021-03       Impact factor: 44.182

8.  Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease.

Authors:  Un Jung Kang; Amelia K Boehme; Graham Fairfoul; Mohammad Shahnawaz; Thong Chi Ma; Samantha J Hutten; Alison Green; Claudio Soto
Journal:  Mov Disord       Date:  2019-03-06       Impact factor: 9.698

9.  Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy.

Authors:  Lucia Rota; Carolina Pellegrini; Laura Benvenuti; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Antonino Cattaneo; Emanuela Colla
Journal:  Transl Neurodegener       Date:  2019-02-06       Impact factor: 8.014

10.  α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies.

Authors:  Matilde Bongianni; Anna Ladogana; Stefano Capaldi; Sigrid Klotz; Simone Baiardi; Annachiara Cagnin; Daniela Perra; Michele Fiorini; Anna Poleggi; Giuseppe Legname; Tatiana Cattaruzza; Francesco Janes; Massimo Tabaton; Bernardino Ghetti; Salvatore Monaco; Gabor G Kovacs; Piero Parchi; Maurizio Pocchiari; Gianluigi Zanusso
Journal:  Ann Clin Transl Neurol       Date:  2019-10-10       Impact factor: 4.511

View more
  1 in total

1.  Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies.

Authors:  Mie Kristine Just; Hjalte Gram; Vasileios Theologidis; Poul Henning Jensen; K Peter R Nilsson; Mikael Lindgren; Karoline Knudsen; Per Borghammer; Nathalie Van Den Berge
Journal:  Front Aging Neurosci       Date:  2022-05-26       Impact factor: 5.702

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.